The future of digital identity: DNA, AI and blockchains, Alan Radford, explores the potential of DNA-based identity verification through blockchain technology and the evolving role of nonhuman identities in the digital age.
A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct
OriGene offers CRISPR/Cas9, the latest and effective tool for genome editing. This webinar covers the basics of the CRISPR/Cas9 system, as well as the applications of this novel technology